|
1
|
Thom T, Haase N, Rosamond W, Howard VJ,
Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S,
et al: American Heart Association Statistics Committee and Stroke
Statistics Subcommittee: Heart disease and stroke statistics - 2006
update: A report from the American Heart Association Statistics
Committee and Stroke Statistics Subcommittee. Circulation.
113:e85–e151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nabel EG and Braunwald E: A tale of
coronary artery disease and myocardial infarction. N Engl J Med.
366:54–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiong M, Wang ZV, Pedrozo Z, Cao DJ,
Troncoso R, Ibacache M, Criollo A, Nemchenko A, Hill JA and
Lavandero S: Cardiomyocyte death: Mechanisms and translational
implications. Cell Death Dis. 2:e2442011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu
Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, et al:
Glycogen synthase kinase-3beta mediates convergence of protection
signaling to inhibit the mitochondrial permeability transition
pore. J Clin Invest. 113:1535–1549. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nishihara M, Miura T, Miki T, Tanno M,
Yano T, Naitoh K, Ohori K, Hotta H, Terashima Y and Shimamoto K:
Modulation of the mitochondrial permeability transition pore
complex in GSK-3beta-mediated myocardial protection. J Mol Cell
Cardiol. 43:564–570. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Steinbrecher KA, Wilson W III, Cogswell PC
and Baldwin AS: Glycogen synthase kinase 3beta functions to specify
gene-specific, NF-kappaB-dependent transcription. Mol Cell Biol.
25:8444–8455. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaga S, Zhan L, Altaf E and Maulik N:
Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and
anti-apoptotic signaling through the induction of VEGF, Bcl-2 and
survivin expression in rat ischemic preconditioned myocardium. J
Mol Cell Cardiol. 40:138–147. 2006. View Article : Google Scholar
|
|
8
|
Liu J, Stevens J, Matsunami N and White
RL: Targeted degradation of beta-catenin by chimeric F-box fusion
proteins. Biochem Biophys Res Commun. 313:1023–1029. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abe K and Kimura H: The possible role of
hydrogen sulfide as an endogenous neuromodulator. J Neurosci.
16:1066–1071. 1996.PubMed/NCBI
|
|
10
|
Wang R: Two's company, three's a crowd:
Can H2S be the third endogenous gaseous transmitter? FASEB J.
16:1792–1798. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen YH, Yao WZ, Geng B, Ding YL, Lu M,
Zhao MW and Tang CS: Endogenous hydrogen sulfide in patients with
COPD. Chest. 128:3205–3211. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Porokhya MV, Abramochkin DV, Abramov AA,
Kuzmin VS and Sukhova GS: Inotropic effects of gaseous transmitters
in isolated rat heart preparation. Bull Exp Biol Med. 153:855–857.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu X, Li T, Bi S, Jin Z, Zhou G, Bai C, Li
L, Cui Q and Liu W: Possible role of hydrogen sulfide on the
preservation of donor rat hearts. Transplant Proc. 39:3024–3029.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lavu M, Bhushan S and Lefer DJ: Hydrogen
sulfide-mediated cardioprotection: Mechanisms and therapeutic
potential. Clin Sci (Lond). 120:219–229. 2011. View Article : Google Scholar
|
|
15
|
Sikora M, Drapala A and Ufnal M: Exogenous
hydrogen sulfide causes different hemodynamic effects in
normotensive and hypertensive rats via neurogenic mechanisms.
Pharmacological Rep. 66:751–758. 2014. View Article : Google Scholar
|
|
16
|
Li L, Liu D, Bu D, Chen S, Wu J, Tang C,
Du J and Jin H: Brg1-dependent epigenetic control of vascular
smooth muscle cell proliferation by hydrogen sulfide. Biochim
Biophys Acta. 1833.1347–1355. 2013.
|
|
17
|
Mostofa MG, Saegusa D, Fujita M and Tran
LS: Hydrogen sulfide regulates salt tolerance in rice by
maintaining Na(+)/K(+) balance, mineral homeostasis and oxidative
metabolism under excessive salt stress. Front Plant Sci.
6(1055)2015. View Article : Google Scholar
|
|
18
|
Sivarajah A, Collino M, Yasin M, Benetti
E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R and Thiemermann
C: Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide
in a rat model of regional myocardial I/R. Shock. 31:267–274. 2009.
View Article : Google Scholar
|
|
19
|
Rios EC, Szczesny B, Soriano FG, Olah G
and Szabo C: Hydrogen sulfide attenuates cytokine production
through the modulation of chromatin remodeling. Int J Mol Med.
35:1741–1746. 2015.PubMed/NCBI
|
|
20
|
Bhindi R, Witting PK, McMahon AC,
Khachigian LM and Lowe HC: Rat models of myocardial infarction.
Pathogenetic insights and clinical relevance. Thromb Haemost.
96:602–610. 2006.PubMed/NCBI
|
|
21
|
Lee TM, Lin MS and Chang NC: Effect of
ATP-sensitive potassium channel agonists on ventricular remodeling
in healed rat infarcts. J Am Coll Cardiol. 51:1309–1318. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu F, Liu GJ, Liu N, Zhang G, Zhang JX
and Li LF: Effect of hydrogen sulfide on inflammatory cytokines in
acute myocardial ischemia injury in rats. Exp Ther Med.
9:1068–1074. 2015.PubMed/NCBI
|
|
23
|
Johansen D, Ytrehus K and Baxter GF:
Exogenous hydrogen sulfide (H2S) protects against
regional myocardial ischemia-reperfusion injury - Evidence for a
role of K ATP channels. Basic Res Cardiol. 101:53–60. 2006.
View Article : Google Scholar
|
|
24
|
Chen QL, Gu EW, Zhang L, Cao YY, Zhu Y and
Fang WP: Diabetes mellitus abrogates the cardioprotection of
sufentanil against ischaemia/reperfusion injury by altering
glycogen synthase kinase-3β. Acta Anaesthesiol Scand. 57:236–242.
2013. View Article : Google Scholar
|
|
25
|
Gross ER, Hsu AK and Gross GJ: Diabetes
abolishes morphine-induced cardioprotection via multiple pathways
upstream of glycogen synthase kinase-3beta. Diabetes. 56:127–136.
2007. View Article : Google Scholar
|
|
26
|
Obame FN, Plin-Mercier C, Assaly R, Zini
R, Dubois-Randé JL, Berdeaux A and Morin D: Cardioprotective effect
of morphine and a blocker of glycogen synthase kinase 3 beta,
SB216763
[3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione],
via inhibition of the mitochondrial permeability transition pore. J
Pharmacol Exp Ther. 326:252–258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao W, Zhang J, Lu Y and Wang R: The
vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP)
channel opener. EMBO J. 20:6008–6016. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z, Huang H, Liu P, Tang C and Wang
J: Hydrogen sulfide contributes to cardioprotection during
ischemia-reperfusion injury by opening K ATP channels. Can J
Physiol Pharmacol. 85:1248–1253. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen SS, Tang CS, Jin HF and Du JB: Sulfur
dioxide acts as a novel endogenous gaseous signaling molecule in
the cardiovascular system. Chin Med J (Engl). 124:1901–1905.
2011.
|
|
30
|
Yang G, Sun X and Wang R: Hydrogen
sulfide-induced apoptosis of human aorta smooth muscle cells via
the activation of mitogen-activated protein kinases and caspase-3.
FASEB J. 18:1782–1784. 2004.PubMed/NCBI
|
|
31
|
Whiteman M, Cheung NS, Zhu YZ, Chu SH,
Siau JL, Wong BS, Armstrong JS and Moore PK: Hydrogen sulphide: A
novel inhibitor of hypochlorous acid-mediated oxidative damage in
the brain? Biochem Biophys Res Commun. 326:794–798. 2005.
View Article : Google Scholar
|
|
32
|
Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath
RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M and Moore PK:
Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced
inflammation in the mouse. FASEB J. 19:1196–1198. 2005.PubMed/NCBI
|
|
33
|
Tokuda K, Kida K, Marutani E, Crimi E,
Bougaki M, Khatri A, Kimura H and Ichinose F: Inhaled hydrogen
sulfide prevents endotoxin-induced systemic inflammation and
improves survival by altering sulfide metabolism in mice. Antioxid
Redox Signal. 17:11–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang LH, Luo X, He W, Huang XX and Cheng
TT: Effects of exogenous hydrogen sulfide on apoptosis proteins and
oxidative stress in the hippocampus of rats undergoing heroin
withdrawal. Arch Pharm Res. 34:2155–2162. 2011. View Article : Google Scholar
|
|
35
|
Sodha NR1, Clements RT, Feng J, Liu Y,
Bianchi C, Horvath EM, Szabo C and Sellke FW: The effects of
therapeutic sulfide on myocardial apoptosis in response to
ischemia-reperfusion injury. Eur J Cardiothorac Surg. 33:906–913.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tian Y, Zhang W, Xia D, Modi P, Liang D
and Wei M: Postconditioning inhibits myocardial apoptosis during
prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway. J Biomed Sci.
18(53)2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kumar D and Jugdutt BI: Apoptosis and
oxidants in the heart. J Lab Clin Med. 142:288–297. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu F, Xing J, Zhang X, Dong S, Zhao Y,
Wang L, Li H, Yang F, Xu C and Zhang W: Exogenous hydrogen sulfide
prevents cardiomyocyte apoptosis from cardiac hypertrophy induced
by isoproterenol. Mol Cell Biochem. 381:41–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cook SA, Sugden PH and Clerk A: Regulation
of bcl-2 family proteins during development and in response to
oxidative stress in cardiac myocytes: Association with changes in
mitochondrial membrane potential. Circ Res. 85:940–949. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bharti S, Golechha M, Kumari S, Siddiqui
KM and Arya DS: Akt/GSK-3β/eNOS phosphorylation arbitrates
safranal-induced myocardial protection against ischemia-reperfusion
injury in rats. Eur J Nutr. 51:719–727. 2012. View Article : Google Scholar
|
|
41
|
Bharti S, Singh R, Chauhan SS, Hussain T,
Al-Attas OS and Arya DS: Phosphorylation of Akt/GSK-3β/eNOS
amplifies 5-HT2B receptor blockade mediated anti-hypertrophic
effect in rats. FEBS Lett. 586:180–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lu Y, Zhou J, Xu C, Lin H, Xiao J, Wang Z
and Yang B: JAK/STAT and PI3K/AKT pathways form a mutual
transactivation loop and afford resistance to oxidative
stress-induced apoptosis in cardiomyocytes. Cell Physiol Biochem.
21:305–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yadav HN, Singh M and Sharma PL:
Involvement of GSK-3β in attenuation of the cardioprotective effect
of ischemic preconditioning in diabetic rat heart. Mol Cell
Biochem. 343:75–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Desrois M, Sidell RJ, Gauguier D, King LM,
Radda GK and Clarke K: Initial steps of insulin signaling and
glucose transport are defective in the type 2 diabetic rat heart.
Cardiovasc Res. 61:288–296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Coghlan MP, Culbert AA, Cross DA, Corcoran
SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee
Cox L, et al: Selective small molecule inhibitors of glycogen
synthase kinase-3 modulate glycogen metabolism and gene
transcription. Chem Biol. 7:793–803. 2000. View Article : Google Scholar : PubMed/NCBI
|
